in recent days, Life Daily reporters visited the drugstore including Chu Yu, Hui and Ping Jia, and the price of Erythromycin Eye Ointment was 0.4 yuan -4.8 yuan. The prices of Erythromycin Eye Ointment from different manufacturers are different, but the price of the same product varies with the same manufacturer.
for Erythromycin Eye Ointment, there are two main types of circulation in the market at present: Erythromycin Eye Ointment, 2.5 g, 4.8 yuan and 2 grams per branch of Beijing double Ji pharmaceutical production, and the price range from 0.4 yuan to 3.5 yuan.
when a reporter consults at a drugstore in the West passenger station to buy Erythromycin Eye Ointment, the drugstore staff recommends the eye ointment produced by Beijing Shuang Ji pharmaceutical. When the reporter said whether there was an ointment produced by Chen Xin, the staff found that there was not much left, and the selling would not necessarily go to Chen Xin's medicine industry. "We do not know what the reason is, it is the company's unified purchase."
when asked why not to buy a cheap Erythromycin Eye Ointment in the pharmaceutical industry, the staff said they did not know, "in fact, this manufacturer is also rising, 3 hair, then 5 Mao, now 8 hair."
the staff of the pharmacy of Li Jian pharmacy said that they sold Erythromycin Eye Ointment of Chen Xin Pharmaceutical Industry for 3.5 yuan. If it is a member of the pharmacy, it only needs a few cents, and the member is free to deal with it.
"we have been 0.4 yuan here," the staff of the Ping Jia big pharmacy said that the Erythromycin Eye Ointment they sold had always been Chen Xin Pharmaceutical, and the price had not changed. The price of Beijing Shuang Ji pharmaceutical production is higher.
a staff member, named Ming Kang drugstore, told reporters that their home sold Erythromycin Eye Ointment of Chen Xin pharmaceutical industry, up to 3.5 yuan per unit since last year.
Community Health Service Center: the manufacturer's price rise
the staff of the community health service center for common drug prices in the homes of the people.
"we are all 100% from the government procurement platform for procurement, and all zero difference, a lot of people come to our community service center always said that the price of medicine has risen, but in fact, we can not be weak, we can only do a good job."
a staff member of a community health service said, for example, gentamicin, which has recently risen considerably, has risen from the 0.26/ to 0.83 yuan, but this is the price rise of the manufacturer, not related to the hospital and the community health service center. "The price is not about the price we can do."
so when Erythromycin Eye Ointment adjusted its price around March this year, people were complaining about the increase in price, but the hospital was powerless. To this end, in recent two or three months, many community hospitals are facing shortages of medicines such as Erythromycin Ointment and gluten. "Pharmacy is not a zero price difference in drugs, they can enter other manufacturers' drugs instead of the original manufacturers, so the drugstores need less medicine."
pharmaceutical factory: the reason why the price rise is "inconvenient to leak out"
what is the reason why the effective price of cheap drugs rise or be out of stock?
recently, the reporter found the catalogue of the drug purchasing consortium of the basic medical institutions in Ji'nan, which includes dexamethasone phosphorus, from the centralized purchase network of Shandong province. Sodium injection, erythromycin, Gentamycin Sulfate Injection and a variety of pharmaceutical manufacturers, such as a variety of pharmaceutical manufacturers Chen Xin Limited by Share Ltd, "this is not convenient for me to leak, this is the decision of the leadership." Reporters call the company's sales call, the staff said. When the reporter said whether he could tell the leader and interview the leader, the other party hung up the phone.
the next reporter also inquired from the network of Shandong Ren He Tang Pharmaceutical Co., Ltd. by telephone from the Internet, and the 4 calls that were found were unable to be connected.
industry analysis: alert manufacturers to form price alliances to raise price
price increases:
1. raw materials increase, such as Glycyrrhiza
2. quality standards, the cost of pharmaceutical companies increase
3. non profit and cheap drugs to withdraw,
4. individual manufacturers are dark. The price of Glycyrrhiza Glycyrrhiza, which needs Chinese medicinal herbs as the main raw material, is inevitable because the price of licorice is indeed on the rise, and the pharmaceutical enterprises must not be able to make a loss on the price of
" to be honest, the cost of pharmaceutical enterprises has been greatly improved because of the introduction of the consensus evaluation opinion. The general small pharmaceutical factories can not afford the consistency evaluation. Only the large industrial enterprises have the ability and the strength to do the consistent evaluation. This undoubtedly leads to the improvement of the cost, and the pharmaceutical enterprises will certainly also price the price. Rise. " Liu said, since last year, many drugs have been rising, and some even several times a few times the increase, "we can not do anything, but for the people's heart is easy to accept, many drugs we are flat or even lose money sales, for example, some drugs before the price of 35 cents, now the price is 5 yuan, a lot of money, a lot of money, a lot of money, a lot of money, a lot of money, a lot of money, a lot of money, a lot of money, a lot of money, a lot of money, many People feel that the increase is too big to accept. We sell it for three yuan. "
another industry personage Mr. Zhou analyzed the cheap drugs used in the past, such as Erythromycin Ointment, periodontil, calcium gluconate, chlorpheniramine, and so on. The price is low and the profit is thin. If the price of the raw material is rising again, this kind of cheap medicine has no room for profit at all. It can only be forced out of the market and is replaced by a similar composition. Imported drugs or high priced drugs. "The ultimate damage is the patient."
Mr. Zhou's analysis of the high price of raw materials is that the supply of raw materials is less than demand. As the manufacturer of API must be approved and approved by the relevant departments of the state, the number of manufacturers approving production is small. Once manufacturers secretly form alliances or dealers to form alliances, the market will be controlled. The supply of raw materials will artificially raise the price of raw materials.
perhaps, Mr. Zhou's words are not empty. In March of this year, the Shandong Provincial Bureau of prices punished Weifang long Shun and Pharmaceutical Co., Ltd. in accordance with the anti monopoly law, and fined 120 thousand yuan. In the second half of last year, the national development and Reform Commission (NDRC) issued news on the official website that 3 companies in Central China, Shandong Xinyi and Changzhou four drugs have been fined according to the law of the estalolen monopoly agreement, a total of more than 260 yuan, and 3 companies have been ordered to stop the implementation of the monopoly agreement immediately. It is understood that there are only 4 enterprises in China that have received approval for the production of alisalam, but only Huazhong pharmaceutical, Shandong Xinyi and Changzhou four drugs are actually produced.